107 related articles for article (PubMed ID: 19681063)
1. Rituximab (B-cell depleting antibody) associated lung injury (RALI): a pediatric case and systematic review of the literature.
Bitzan M; Anselmo M; Carpineta L
Pediatr Pulmonol; 2009 Sep; 44(9):922-34. PubMed ID: 19681063
[TBL] [Abstract][Full Text] [Related]
2. A mild form of rituximab-associated lung injury in two adolescents treated for nephrotic syndrome.
Spatafora M; Bellini T; Giordano C; Ghiggeri GM
BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26661285
[TBL] [Abstract][Full Text] [Related]
3. Fatal rituximab-associated lung injury syndrome in a patient treated with rituximab for recurrence of post-transplant nephrotic syndrome.
Grenda R; Jarmużek W; Rubik J; Migdał M; Pronicki M
Pediatr Transplant; 2015 Aug; 19(5):E115-20. PubMed ID: 25929598
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
[TBL] [Abstract][Full Text] [Related]
5. Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy.
Benz K; Dötsch J; Rascher W; Stachel D
Pediatr Nephrol; 2004 Jul; 19(7):794-7. PubMed ID: 15071769
[TBL] [Abstract][Full Text] [Related]
6. Bronchiolitis obliterans-organizing pneumonia: an Italian experience.
Cazzato S; Zompatori M; Baruzzi G; Schiattone ML; Burzi M; Rossi A; Ratta L; Terzuolo G; Falcone F; Poletti V
Respir Med; 2000 Jul; 94(7):702-8. PubMed ID: 10926343
[TBL] [Abstract][Full Text] [Related]
7. [Rituximab therapy for severe pediatric systemic lupus erythematosus].
Su GX; Wu FQ; Wang F; Zhou ZX; Huang XL; Lu J
Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):697-704. PubMed ID: 23158822
[TBL] [Abstract][Full Text] [Related]
8. Bronchiolitis obliterans with organizing pneumonia after rituximab therapy for non-Hodgkin's lymphoma.
Biehn SE; Kirk D; Rivera MP; Martinez AE; Khandani AH; Orlowski RZ
Hematol Oncol; 2006 Dec; 24(4):234-7. PubMed ID: 16948177
[TBL] [Abstract][Full Text] [Related]
9. Non-infectious pulmonary toxicity of rituximab: a systematic review.
Hadjinicolaou AV; Nisar MK; Parfrey H; Chilvers ER; Ostör AJ
Rheumatology (Oxford); 2012 Apr; 51(4):653-62. PubMed ID: 22157468
[TBL] [Abstract][Full Text] [Related]
10. Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients.
Milpied N; Vasseur B; Parquet N; Garnier JL; Antoine C; Quartier P; Carret AS; Bouscary D; Faye A; Bourbigot B; Reguerre Y; Stoppa AM; Bourquard P; Hurault de Ligny B; Dubief F; Mathieu-Boue A; Leblond V
Ann Oncol; 2000; 11 Suppl 1():113-6. PubMed ID: 10707791
[TBL] [Abstract][Full Text] [Related]
11. Rituximab is not a "magic drug" in post-transplant recurrence of nephrotic syndrome.
Grenda R; Jarmużek W; Rubik J; Piątosa B; Prokurat S
Eur J Pediatr; 2016 Sep; 175(9):1133-1137. PubMed ID: 27364906
[TBL] [Abstract][Full Text] [Related]
12. Rituximab-induced lung disease: A systematic literature review.
Lioté H; Lioté F; Séroussi B; Mayaud C; Cadranel J
Eur Respir J; 2010 Mar; 35(3):681-7. PubMed ID: 19608586
[TBL] [Abstract][Full Text] [Related]
13. Rituximab treatment for adults with refractory nephrotic syndrome: a single-center experience and review of the literature.
Kisner T; Burst V; Teschner S; Benzing T; Kurschat CE
Nephron Clin Pract; 2012; 120(2):c79-85. PubMed ID: 22286071
[TBL] [Abstract][Full Text] [Related]
14. [No effect of rituximab in pediatric case of severe nephrotic syndrome and focal segmental glomeruloslerosis accompanied by renal insufficiency].
Hyla-Klekot L; Grenda R; Pulcer B
Pol Merkur Lekarski; 2008 Dec; 25(150):519-22. PubMed ID: 19205386
[TBL] [Abstract][Full Text] [Related]
15. Ofatumumab in two pediatric nephrotic syndrome patients allergic to rituximab.
Vivarelli M; Colucci M; Bonanni A; Verzani M; Serafinelli J; Emma F; Ghiggeri G
Pediatr Nephrol; 2017 Jan; 32(1):181-184. PubMed ID: 27687621
[TBL] [Abstract][Full Text] [Related]
16. [Clinical analysis of rituximab-induced interstitial lung disease].
Huang C; Lu ZW; Yang YQ; Chen H; Huang DP; He HS
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Oct; 40(10):730-735. PubMed ID: 29050126
[No Abstract] [Full Text] [Related]
17. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
[TBL] [Abstract][Full Text] [Related]
18. The indications, efficacy and adverse events of rituximab in a large cohort of patients with juvenile-onset SLE.
Watson L; Beresford MW; Maynes C; Pilkington C; Marks SD; Glackin Y; Tullus K
Lupus; 2015 Jan; 24(1):10-7. PubMed ID: 25117653
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate Mofetil Following Rituximab in Children With Steroid-Resistant Nephrotic Syndrome.
Basu B; Mahapatra TK; Mondal N
Pediatrics; 2015 Jul; 136(1):e132-9. PubMed ID: 26101364
[TBL] [Abstract][Full Text] [Related]
20. Cryptogenic organizing pneumonitis during oxaliplatin chemotherapy for colorectal cancer: case report.
Garrido M; O'Brien A; González S; Clavero JM; Orellana E
Chest; 2007 Dec; 132(6):1997-9. PubMed ID: 18079234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
